M

McKesson

Supplies medicines and technology to healthcare teams

Inventory Control Manager

Full-TimeUpdated on 10/24/2026
$62k - $103.4k+ Annual bonus + Long-term incentive opportunities
Senior
Bachelor's
Shepherdsville, KY, USA
In PersonPrimarily based within a distribution center; occasional travel may be required.
Warehouse & FulfillmentInventory Control & Cycle Counting

About the job

Requirements
  • A bachelor's degree in Supply Chain, Logistics, Operations Management, Business, Industrial Engineering, or a related field, or an equivalent combination of education and experience.
  • Typically requires 7 or more years of relevant professional experience, including leadership experience, or an equivalent combination of education and experience.
  • Experience leading inventory control, warehouse operations, supply chain operations, or distribution center teams.
  • Experience managing inventory accuracy, cycle counting, physical inventories, reconciliations, and inventory investigations.
  • Experience using Warehouse Management Systems (WMS), ERP platforms, and inventory reporting tools.
  • Demonstrated experience leading teams and driving operational performance.
  • Experience working in regulated environments requiring compliance and audit readiness.
Responsibilities
  • Lead, coach, and develop Inventory Supervisors, Team Leads, and Inventory Specialists.
  • Establish performance expectations and monitor results against operational and customer key performance indicators.
  • Support workforce planning, staffing, training, and employee development initiatives.
  • Foster a culture of accountability, engagement, safety, and continuous improvement.
  • Manage inventory control processes, including cycle counts, physical inventories, reconciliations, investigations, inventory adjustments, and supply management.
  • Ensure inventory accuracy meets or exceeds company and customer standards.
  • Monitor inventory transactions and system integrity within Warehouse Management Systems and enterprise resource planning platforms.
  • Analyze inventory performance data to identify trends, risks, and improvement opportunities.
  • Oversee inventory disposition activities, including expiration management, product holds, recalls, quarantined inventory, and product destruction.
  • Ensure compliance with current Good Manufacturing Practices, Food and Drug Administration, Drug Enforcement Administration, Occupational Safety and Health Administration, customer, and company requirements.
  • Maintain audit readiness and support internal, customer, regulatory, and quality audits.
  • Review and manage inventory-related standard operating procedures, work instructions, and controlled documentation.
  • Support investigations, corrective and preventive actions, change controls, and quality system initiatives.
  • Monitor and report key inventory metrics, including inventory accuracy, cycle count performance, inventory aging, adjustments, and service-related issues.
  • Conduct root cause analysis and implement corrective actions to prevent recurrence.
  • Lead process improvement initiatives that enhance inventory accuracy, productivity, compliance, and customer satisfaction.
  • Support inventory strategy, capacity planning, and operational growth initiatives.
  • Collaborate with Operations, Quality, Transportation, Maintenance, Information Technology, Customer Care, and Client Services teams.
  • Serve as a primary inventory subject matter expert for customers, auditors, and internal stakeholders.
  • Support client implementations, inventory migrations, and operational improvement projects.
  • Work primarily within a distribution center and frequently interact with warehouse operations and inventory storage areas.
  • Walk warehouse floors and conduct inventory observations and audits.
  • Travel occasionally to support customer, operational, or business initiatives.
Desired Qualifications
  • Experience within pharmaceutical, healthcare, medical device, biotechnology, or regulated third-party logistics distribution environments.
  • Knowledge of Food and Drug Administration, Drug Enforcement Administration, current Good Manufacturing Practices, Good Distribution Practices, and quality system requirements.
  • Lean, Six Sigma, Continuous Improvement, or Operational Excellence certification.
  • Experience leading multi-site inventory operations or network-wide inventory initiatives.
  • Advanced analytical and reporting capabilities, including Power BI or similar business intelligence tools.
  • Strong customer-facing experience and client relationship management skills.
  • Experience with inventory optimization, automation, or process digitization initiatives.
  • Working knowledge of cold-chain, temperature-controlled inventory, or controlled substance management.

About the company

McKesson distributes medicines and medical supplies to pharmacies, hospitals and other care providers, alongside services that connect drug manufacturers with patients. Its specialty businesses support community cancer care and clinical research, extending its work beyond moving products through warehouses. The company buys drugs and supplies from manufacturers for resale, while its software helps pharmacies manage inventory and healthcare teams secure insurance approval for prescriptions. It also sells practice management and patient support services to clinicians and drugmakers. McKesson traces its business roots to 1833 and is headquartered in Irving, Texas.

Company Size

10,001+

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1833

Get referred to McKesson

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Reinvestment has cash behind it: McKesson reported $6.2 billion operating cash flow for fiscal 2026 in May 2026.
  • Specialty expansion drives growth: McKesson reported 31% higher fiscal 2026 Oncology and Multispecialty sales in May 2026.
  • Technical candidates have openings: McKesson lists 154 information technology jobs on its career site in October 2026.

What critics are saying

  • One customer holds bargaining power: CVS generated 24% of McKesson's fiscal 2026 revenue, reported in May 2026.
  • Technology jobs face cuts: McKesson approved prescription technology headcount reductions during January through March 2026.
  • Medical supply careers face separation: McKesson outlined a planned Medical-Surgical IPO alongside Apollo's investment agreement in April 2026.

What makes McKesson unique

  • McKesson backs independent ownership: its Health Mart franchise supports pharmacies that remain independently owned and operated.
  • Generic purchasing has a retail partner: McKesson and Walmart jointly source medicines through ClarusONE.
  • McKesson reaches prescribing workflows: CoverMyMeds processes insurance approval requests free for clinicians across all plans and medications.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Performance Bonus
  • 401(k) Company Match

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 23rd, 2026
Fastenal and McKesson are cash-rich stocks to buy this week; Carlisle is one to avoid

StockStory has named two cash-producing stocks to buy this week and one to avoid, saying cash generation alone doesn't make a company a winner. The stock to avoid is Carlisle (NYSE:CSL), a construction materials and weatherproofing maker with a 17% trailing 12-month free cash flow margin. StockStory cites weak organic revenue growth, projected sales growth of 5.8%, and annual earnings per share growth of just 3.6% over two years. Shares trade at $352.84, or 15.1x forward earnings. Fastenal (NASDAQ:FAST), with a 13% free cash flow margin, has a 45.3% gross margin, a 20.5% operating margin, and a 32.3% return on capital. Its shares trade at $52.32, or 38x forward earnings. McKesson (NYSE:MCK) has a 1.5% margin. Sales grew 14.5% annually over two years, and revenue reached $411 billion. Shares trade at $1,010, or 21.8x forward earnings.

AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

TradingView
Oct 6th, 2026
CD&R and McKesson to acquire Option Care Health.

CD&R and McKesson to acquire Option Care Health. WASHINGTON (dpa-AFX) - CD&R, McKesson (MCK) and Option Care Health (OPCH) have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. Upon completion, Option Care Health will become a privately held company. CD&R will hold a majority interest of approximately 51% in Option Care Health and McKesson will invest approximately $1.4 billion for a minority interest of approximately 49%. The deal establishes a framework for McKesson's future acquisition of CD&R's interest in Option Care Health, subject to specified conditions and regulatory approvals. Option Care Health is an independent provider of home and alternate site infusion services. In pre-market trading on NasdaqGS, Option Care shares are up 20.50 percent to $28.16. For More Such Health News, visit rttnews.com. Copyright(c) 2026 RTTNews.com. All Rights Reserved Copyright RTT News/dpa-AFX Read the full article

McKesson Corporation
Oct 1st, 2026
McKesson wins Vizient's 2026 Distribution Excellence Award.

McKesson wins Vizient's 2026 Distribution Excellence Award. Vizient's 2026 Distribution Excellence Award honors suppliers that consistently deliver exceptional service and value to Vizient member health systems. September 29, 2026 In September 2026, Vizient presented McKesson with the 2026 Distribution Excellence Award at the Vizient Connections Summit in Las Vegas. The award recognizes suppliers that demonstrate superior service, support, reliability, ethics, and integrity in collaboration with Vizient.[1] Vizient, a member-owned healthcare performance improvement company, works with thousands of not-for-profit health systems and affiliates. Through its network, Vizient connects healthcare leaders with data, insights, and supplier relationships designed to drive value across the enterprise. For McKesson, the recognition reflects years of building a strategic, enterprise-wide relationship with Vizient and its member organizations at a time when health systems increasingly rely on collaborative partnerships to navigate complexity across pharmacy, supply chain, and clinical operations. Ali Cobb, Vice President of Health Systems National Accounts for McKesson Health Systems, has been central to strengthening collaboration and identifying new ways to support member needs. As workforce pressures, financial constraints, and supply chain challenges continue to shape healthcare, strong strategic partnerships remain critical to helping health systems build resilience and advance patient health. This award reflects a shared commitment by Vizient and McKesson to help health systems meet today's demands while preparing for what's next, together.

JH Consulting Online
Sep 22nd, 2026
Cara McDonough joins McKesson Medical-Surgical as Chief Product Strategy & Supplier Partnerships Officer.

Cara McDonough joins McKesson Medical-Surgical as Chief Product Strategy & Supplier Partnerships Officer. September 22, 2026- McKesson Medical-Surgical has announced that Cara McDonough has joined the organization as Chief Product Strategy & Supplier Partnerships Officer, effective September 14, 2026. In this role, Cara will lead McKesson Medical-Surgical's Product Strategy and Supplier Partnerships teams, guiding supplier relationship strategy and portfolio development across the company's Private Label, Pharmaceutical, Consumer Markets, and Laboratory businesses as a member of the Executive Committee. Cara brings 20 years of experience leading and growing product-focused organizations. Throughout her career, she has held senior leadership positions with nationally recognized companies, driving merchandising, private label, product strategy, and commercial growth across multiple channels, including B2B, e-commerce, and retail. Her experience building differentiated product portfolios, strengthening supplier relationships, and delivering profitable growth aligns closely with the organization's long-term strategy. As McKesson Medical-Surgical continues evolving its business, Cara's leadership will help further strengthen supplier partnerships and support the organization's commitment to delivering innovative solutions and value to customers.